Technical Articles

KRAS G12C/cRAF结合检测:靶向药物筛选与机制研究新工具
KRAS G12C/cRAF binding assay: A novel tool for targeted drug screening and mechanism research
发布时间 2026-02-27
The RAS family genes are among the most frequently mutated oncogenes in human cancers, with KRAS mutations being particularly common and exhibiting high incidence in malignancies such as pancreatic cancer, colorectal cancer, and non-small cell lung cancer.
View details
  • Cancer
  • Human KRAS G12C & cRAF Binding Kit
  • Pancreatic cancer
  • Colorectal cancer
Total 1
  • 1
Go to